Gastric bypass in Type 2 diabetes with BMI < 30: Weight and weight loss have a major influence on outcomes

J. B. Dixon, K. Y. Hur, W. J. Lee, M. J. Kim, K. Chong, S. C. Chen, N. E. Straznicky, P. Zimmet

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Aim To assess factors influencing glycaemic control following gastric bypass surgery in patients with Type 2 diabetes and BMI< 30 kg/m2. Methods Prospective longitudinal study of 103 patients with inadequate glycaemic control who underwent gastric bypass surgery at Soonchunhyang University, Seoul, Korea (n = 66) and Min-Sheng General Hospital, Taipei, Taiwan (n = 37). Procedures were performed August 2009 to January 2011. Key outcome measures were excellent glycaemic control of Type 2 diabetes defined as HbA1c < 42 mmol/mol (≥ 6%); inadequate response defined as HbA1c > 53 mmol/ mol (> 7%). Analysis was conducted using binary logistic regression, and cut-points obtained from receiver operator characteristics. Results Excellent glycaemic control was achieved in 31 (30%) at 1 year. Diabetes duration of < 7 years and BMI > 27 kg/m2 provided independent predictors and useful cut-points. Likelihood of excellent glycaemic control for an individual could be estimated using loge (Odds) = –6.7 + (0.26 × BMI) + (–1.2 9 diabetes duration). Baseline BMI of < 27 kg/m2 and baseline C-peptide of < 2.0ng/ml, best predicted a poor glycaemic response. In those with favourable baseline characteristics percentage weight loss (%WL) had a dominant influence on glycaemic outcomes. Baseline C-peptide (> 2.4 ng/ml) and subsequent percentage weight loss (> 16%) were associated with excellent glycaemic control. Higher BMI was associated with greater percentage weight loss. Conclusion In patients with Type 2 diabetes and BMI < 30 kg/m2, glycaemic response to gastric bypass is predicted by higher baseline BMI, shorter disease duration and higher fasting C-peptide. Post-surgery weight loss has a dominant effect. Baseline BMI and weight loss have a major influence on outcomes.

LanguageEnglish
Pagese127-e134
JournalDiabetic Medicine
Volume30
Issue number4
DOIs
Publication statusPublished - 1 Apr 2013
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Dixon, J. B., Hur, K. Y., Lee, W. J., Kim, M. J., Chong, K., Chen, S. C., ... Zimmet, P. (2013). Gastric bypass in Type 2 diabetes with BMI < 30: Weight and weight loss have a major influence on outcomes. Diabetic Medicine, 30(4), e127-e134. https://doi.org/10.1111/dme.12107
Dixon, J. B. ; Hur, K. Y. ; Lee, W. J. ; Kim, M. J. ; Chong, K. ; Chen, S. C. ; Straznicky, N. E. ; Zimmet, P. / Gastric bypass in Type 2 diabetes with BMI < 30 : Weight and weight loss have a major influence on outcomes. In: Diabetic Medicine. 2013 ; Vol. 30, No. 4. pp. e127-e134.
@article{5a33865b23dc4ec9bc5f3f043acef082,
title = "Gastric bypass in Type 2 diabetes with BMI < 30: Weight and weight loss have a major influence on outcomes",
abstract = "Aim To assess factors influencing glycaemic control following gastric bypass surgery in patients with Type 2 diabetes and BMI< 30 kg/m2. Methods Prospective longitudinal study of 103 patients with inadequate glycaemic control who underwent gastric bypass surgery at Soonchunhyang University, Seoul, Korea (n = 66) and Min-Sheng General Hospital, Taipei, Taiwan (n = 37). Procedures were performed August 2009 to January 2011. Key outcome measures were excellent glycaemic control of Type 2 diabetes defined as HbA1c < 42 mmol/mol (≥ 6{\%}); inadequate response defined as HbA1c > 53 mmol/ mol (> 7{\%}). Analysis was conducted using binary logistic regression, and cut-points obtained from receiver operator characteristics. Results Excellent glycaemic control was achieved in 31 (30{\%}) at 1 year. Diabetes duration of < 7 years and BMI > 27 kg/m2 provided independent predictors and useful cut-points. Likelihood of excellent glycaemic control for an individual could be estimated using loge (Odds) = –6.7 + (0.26 × BMI) + (–1.2 9 diabetes duration). Baseline BMI of < 27 kg/m2 and baseline C-peptide of < 2.0ng/ml, best predicted a poor glycaemic response. In those with favourable baseline characteristics percentage weight loss ({\%}WL) had a dominant influence on glycaemic outcomes. Baseline C-peptide (> 2.4 ng/ml) and subsequent percentage weight loss (> 16{\%}) were associated with excellent glycaemic control. Higher BMI was associated with greater percentage weight loss. Conclusion In patients with Type 2 diabetes and BMI < 30 kg/m2, glycaemic response to gastric bypass is predicted by higher baseline BMI, shorter disease duration and higher fasting C-peptide. Post-surgery weight loss has a dominant effect. Baseline BMI and weight loss have a major influence on outcomes.",
author = "Dixon, {J. B.} and Hur, {K. Y.} and Lee, {W. J.} and Kim, {M. J.} and K. Chong and Chen, {S. C.} and Straznicky, {N. E.} and P. Zimmet",
year = "2013",
month = "4",
day = "1",
doi = "10.1111/dme.12107",
language = "English",
volume = "30",
pages = "e127--e134",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "4",

}

Dixon, JB, Hur, KY, Lee, WJ, Kim, MJ, Chong, K, Chen, SC, Straznicky, NE & Zimmet, P 2013, 'Gastric bypass in Type 2 diabetes with BMI < 30: Weight and weight loss have a major influence on outcomes', Diabetic Medicine, vol. 30, no. 4, pp. e127-e134. https://doi.org/10.1111/dme.12107

Gastric bypass in Type 2 diabetes with BMI < 30 : Weight and weight loss have a major influence on outcomes. / Dixon, J. B.; Hur, K. Y.; Lee, W. J.; Kim, M. J.; Chong, K.; Chen, S. C.; Straznicky, N. E.; Zimmet, P.

In: Diabetic Medicine, Vol. 30, No. 4, 01.04.2013, p. e127-e134.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gastric bypass in Type 2 diabetes with BMI < 30

T2 - Diabetic Medicine

AU - Dixon, J. B.

AU - Hur, K. Y.

AU - Lee, W. J.

AU - Kim, M. J.

AU - Chong, K.

AU - Chen, S. C.

AU - Straznicky, N. E.

AU - Zimmet, P.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Aim To assess factors influencing glycaemic control following gastric bypass surgery in patients with Type 2 diabetes and BMI< 30 kg/m2. Methods Prospective longitudinal study of 103 patients with inadequate glycaemic control who underwent gastric bypass surgery at Soonchunhyang University, Seoul, Korea (n = 66) and Min-Sheng General Hospital, Taipei, Taiwan (n = 37). Procedures were performed August 2009 to January 2011. Key outcome measures were excellent glycaemic control of Type 2 diabetes defined as HbA1c < 42 mmol/mol (≥ 6%); inadequate response defined as HbA1c > 53 mmol/ mol (> 7%). Analysis was conducted using binary logistic regression, and cut-points obtained from receiver operator characteristics. Results Excellent glycaemic control was achieved in 31 (30%) at 1 year. Diabetes duration of < 7 years and BMI > 27 kg/m2 provided independent predictors and useful cut-points. Likelihood of excellent glycaemic control for an individual could be estimated using loge (Odds) = –6.7 + (0.26 × BMI) + (–1.2 9 diabetes duration). Baseline BMI of < 27 kg/m2 and baseline C-peptide of < 2.0ng/ml, best predicted a poor glycaemic response. In those with favourable baseline characteristics percentage weight loss (%WL) had a dominant influence on glycaemic outcomes. Baseline C-peptide (> 2.4 ng/ml) and subsequent percentage weight loss (> 16%) were associated with excellent glycaemic control. Higher BMI was associated with greater percentage weight loss. Conclusion In patients with Type 2 diabetes and BMI < 30 kg/m2, glycaemic response to gastric bypass is predicted by higher baseline BMI, shorter disease duration and higher fasting C-peptide. Post-surgery weight loss has a dominant effect. Baseline BMI and weight loss have a major influence on outcomes.

AB - Aim To assess factors influencing glycaemic control following gastric bypass surgery in patients with Type 2 diabetes and BMI< 30 kg/m2. Methods Prospective longitudinal study of 103 patients with inadequate glycaemic control who underwent gastric bypass surgery at Soonchunhyang University, Seoul, Korea (n = 66) and Min-Sheng General Hospital, Taipei, Taiwan (n = 37). Procedures were performed August 2009 to January 2011. Key outcome measures were excellent glycaemic control of Type 2 diabetes defined as HbA1c < 42 mmol/mol (≥ 6%); inadequate response defined as HbA1c > 53 mmol/ mol (> 7%). Analysis was conducted using binary logistic regression, and cut-points obtained from receiver operator characteristics. Results Excellent glycaemic control was achieved in 31 (30%) at 1 year. Diabetes duration of < 7 years and BMI > 27 kg/m2 provided independent predictors and useful cut-points. Likelihood of excellent glycaemic control for an individual could be estimated using loge (Odds) = –6.7 + (0.26 × BMI) + (–1.2 9 diabetes duration). Baseline BMI of < 27 kg/m2 and baseline C-peptide of < 2.0ng/ml, best predicted a poor glycaemic response. In those with favourable baseline characteristics percentage weight loss (%WL) had a dominant influence on glycaemic outcomes. Baseline C-peptide (> 2.4 ng/ml) and subsequent percentage weight loss (> 16%) were associated with excellent glycaemic control. Higher BMI was associated with greater percentage weight loss. Conclusion In patients with Type 2 diabetes and BMI < 30 kg/m2, glycaemic response to gastric bypass is predicted by higher baseline BMI, shorter disease duration and higher fasting C-peptide. Post-surgery weight loss has a dominant effect. Baseline BMI and weight loss have a major influence on outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84883538969&partnerID=8YFLogxK

U2 - 10.1111/dme.12107

DO - 10.1111/dme.12107

M3 - Article

VL - 30

SP - e127-e134

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 4

ER -